BIO Report

Biotest Aktiengesellschaft
Stock Exchange: XETRA
Sector: biotechnology
42.3
Last session price
42.3
Price now
Currency: EUR
Reporting currency: EUR
ISIN: DE0005227201
INN:
.

BIO financial statements

* Numbers in millions
Year
 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM
Capitalization *
 492 630 1 013 1 299 599 677 1 154 1 003 776 1 140 1 674
EV *
 409 686 1 040 1 452 889 950 1 538 1 271 1 124 1 537 1 537
Stock price €
 13.9833 17.9167 27.0833 32.8333 15.125 17.1 29.15 25.35 19.6 28.8 42.3
Number of shares *
 35 35 37 40 40 40 40 40 40 40 40
EPS
 1,37 0,95 0,86 0,49 -2,08 -1,16 -0,09 4,59 -0,12 -0,79 -0,79
Revenue *
 422 440 501 582 590 553 378 400 419 484 484
Net income *
 48 33 32 19 -83 -46 -4 182 -5 -31 -31
Operating profit *
 42 48 50 52 -72 66 -33 3 -7 -3 -3
Total liabilities *
 336 313 426 552 550 572 631 547 632 690 690
Net debt *
 -83 55 27 153 291 273 384 268 349 398 398
Total assets *
 683 682 887 1 033 963 933 979 1 042 1 108 1 131 1 131
Equity *
 347 369 461 480 412 361 348 495 477 442 442
Cash and investments *
 83 57 204 234 154 83 28 106 86 89 89

Over the past 10 years, the maximum capitalization of Biotest Aktiengesellschaft is 1 299, the minimum is 492.
Maximum net income 182, Minimum net income -83.
The maximum price of BIO shares is 32.8333, the minimum price is 13.9833.

.

BIO valuation

Year
 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM
P/E
 10,22 18,87 31,65 67,67 -7,25 -14,77 -329,57 5,52 -165,02 -36,29 -53,31
P/B
 1,42 1,71 2,20 2,71 1,45 1,88 3,32 2,03 1,63 2,58 3,79
P/S
 1,17 1,43 2,02 2,23 1,02 1,22 3,05 2,51 1,85 2,35 3,46
E/P
 10% 5% 3% 1% -14% -7% 0% 18% -1% -3% -2%
P/FCF
 10,80 2 852,54 -20,22 -23,16 -9,56 -8,68 -15,98 -9,59 -11,46 -26,08 -38,30
.

BIO profitability

Year
 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM
ROE
 14% 9% 7% 4% -20% -13% -1% 37% -1% -7%
ROA
 8% 5% 4% 2% -9% -5% 0% 18% 0% -3%
ROIC
 8% 9% 7% 6% -9% 8% -5% 0% -1% 0%